Role of CD10 Marker in Differentiating Malignant Thyroid Neoplasms from Benign Thyroid Lesions (Immunohistochemical & Histopathological Study) | Zendy

Samia Gabal | Zendy; Mostafa Mohamed Salem | Zendy; Rasha Ramadan Mostafa | Zendy; Shaimaa Mohamed Abdelsalam | Zendy

Open Access

Role of CD10 Marker in Differentiating Malignant Thyroid Neoplasms from Benign Thyroid Lesions (Immunohistochemical & Histopathological Study)

Author(s) -

Samia Gabal,

Mostafa Mohamed Salem,

Rasha Ramadan Mostafa,

Shaimaa Mohamed Abdelsalam

Publication year - 2018

Publication title -

open access macedonian journal of medical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.288

H-Index - 17

ISSN - 1857-9655

DOI - 10.3889/oamjms.2018.456

Subject(s) - medicine , thyroid , pathology , malignancy , immunohistochemistry , thyroid carcinoma , thyroid nodules , follicular phase , lymph node

CD10 was initially recognised as a cell-surface antigen expressed by acute lymphoblastic leukaemias, and hence it's early designation as Common Acute Lymphoblastic Leukemia Antigen (CALLA). Also, it has been proven to be reactive in various non-lymphoid cells and tissue and different types of neoplasms.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research